Steven Gans

3.0k citations

20 papers · 941 indexed · h-index 12

Impact in

Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
Oncology top 5%
- Lung Cancer Research Studies

Papers in ⓘ

Equine 1
Oncology 13
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 2

Co-authors: Bonne Biesma (4 shared papers)Péter Kardos (1 shared paper)J. Thirlwell (1 shared paper)Sergio Harari (1 shared paper)Claus Vogelmeier (1 shared paper)Stephan Stenglein (1 shared paper)C. Debruyne (4 shared papers)Giuseppe Giaccone (4 shared papers)
Journals: Journal of Clinical Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Respiratory Medicine (2 papers)Lung Cancer (2 papers)Clinical Cancer Research (1 paper)
Partner nations: Netherlands United States Belgium

In The Last Decade

Steven Gans

20 papers receiving 913 citations

Peers

Countries citing papers authored by Steven Gans

Since Specialization

Citations

This map shows the geographic impact of Steven Gans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Gans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Gans more than expected).

Fields of papers citing papers by Steven Gans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Gans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Gans. The network helps show where Steven Gans may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Gans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Gans Line = papers co-authored together Steven Gans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Luis Paz‐Ares, Bonne Biesma, David F. Heigener, Joachim von Pawel, Timothy Eisen, Jaafar Bennouna, Li Zhang, Meilin Liao, Yan Sun, Steven Gans, Kostas Syrigos, Etienne Le Marie, Maya Gottfried, Johan Vansteenkiste, V. Alberola, U.P. Strauss, E. Montegriffo, Teng Jin Ong, Armando Santoro	2012	198
2	Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study Respiratory Medicine ·Claus Vogelmeier, Péter Kardos, Sergio Harari, Steven Gans, Stephan Stenglein, J. Thirlwell	2008	140
3	Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955) Journal of Clinical Oncology ·Nico van Zandwijk, Egbert F. Smit, G. Kramer, Franz M.N.H. Schramel, Steven Gans, Jan Festen, A. Termeer, N.J.J. Schlösser, C. Debruyne, Desmond Curran, Giuseppe Giaccone	2000	114
4	Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study Annals of Oncology ·Vivianne C. G. Tjan‐Heijnen, Pieter E. Postmus, Andrea Ardizzoni, C. Manegold, J Burghouts, Jan P. van Meerbeeck, Steven Gans, Marius J. Möllers, E. Buchholz, Bonne Biesma, Catherine Legrand, C. Debruyne, Giuseppe Giaccone	2001	79
5	Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923 Journal of Clinical Oncology ·Andrea Ardizzoni, Vivianne C. G. Tjan‐Heijnen, Pieter E. Postmus, E. Buchholz, Bonne Biesma, H Karnicka-Młodkowska, Rafał Dziadziuszko, J Burghouts, Jan P. van Meerbeeck, Steven Gans, Catherine Legrand, C. Debruyne, Giuseppe Giaccone, Christian Manegold for the	2002	75
6	Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study The Lancet Oncology ·Wieneke A. Buikhuisen, Jacobus A. Burgers, Andrew Vincent, Catharina M. Korse, Rob J. van Klaveren, Franz M.N.H. Schramel, Nick Pavlakis, Anna K. Nowak, Frank L. Custers, J.H. Schouwink, Steven Gans, Harry J.M. Groen, W. F. M. Strankinga, Paul Baas	2013	57
7	Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study Clinical Cancer Research ·Lauren A. Byers, Dmitry Bentsion, Steven Gans, Konstantin Penkov, Choonhee Son, Anne Sibille, Taofeek K. Owonikoko, Harry J.M. Groen, Carl M. Gay, Junya Fujimoto, Patricia M. de Groot, Martin Dunbar, Kingston Kang, Lei He, Vasudha Sehgal, Jaimee Glasgow, Bruce Allen Bach, Peter Ellis	2021	52
8	A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer Lung Cancer ·Giorgio V. Scagliotti, Paul Germonpré, Leon Bosquée, Johan Vansteenkiste, R. Gervais, David Planchard, Martin Reck, Filippo de Marinis, Jin Soo Lee, Keunchil Park, Bonne Biesma, Steven Gans, Rodryg Ramlau, A. Szczęsna, А. Н. Махсон, George Manikhas, Bruno Morgan, Y. Zhu, Kai Chio Chan, Joachim von Pawel	2009	48
9	Hypofractionated external beam radiotherapy as retreatment for symptomatic non–small-cell lung carcinoma: an effective treatment? International Journal of Radiation OncologyBiologyPhysics ·Gijsbert W.P.M. Kramer, Steven Gans, E. Ullmann, Jan P. van Meerbeeck, Catherine Legrand, Jan-Willem H. Leer	2004	45
10	Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 μ g day−1) versus HFA-fluticasone propionate (1000 μ g day−1) in patients with asthma Respiratory Medicine ·Michel Aubier, R WETTENGER, Steven Gans	2001	39
11	Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study European Journal of Cancer ·Giorgio V. Scagliotti, Keunchil Park, Shekar Patil, Janusz Rolski, Tuncay Göksel, Renato Martins, Steven Gans, Carla Visseren‐Grul, Patrick Peterson	2009	32
12	Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole Medical Mycology Case Reports ·Paulien Bunskoek, Seyedmojtaba Seyedmousavi, Steven Gans, Peter B.J. van Vierzen, Willem J. G. Melchers, Cornelis E. van Elk, Johan W. Mouton, Paul E. Verweij	2017	17
13	Pulmonary hyalinizing granuloma European Respiratory Journal ·Steven Gans, A M van der Elst, W. Straks	1988	10
14	Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study Journal of Thoracic Oncology ·Myung‐Ju Ahn, Igor Bondarenko, Ewa Kalinka‐Warzocha, Byoung Chul Cho, Shunichi Sugawara, Gabriella Gálffy, Byoung Yong Shim, Nikolay Kislov, Rajnish Nagarkar, Ingel Demedts, Steven Gans, Dolores Mendoza Oliva, Ross Stewart, Zhongwu Lai, Helen Mann, Xiaojin Shi, Maen Hussein	2023	8
15	Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy ESMO Open ·Edward B. Garon, Giorgio V. Scagliotti, Oliver Gautschi, Martin Reck, Michael Thomas, Lara Iglesias Docampo, Haralabos P. Kalofonos, Joo-Hang Kim, Steven Gans, Oddrje Te Brustugun, Sergey Orlov, Gebra Cuyún Carter, Annamaria H. Zimmermann, Ana B. Oton, Ekaterine Alexandris, Pablo Lee, Katharina Wolff, Victoria Jennifer Stefaniak, Mark A. Socinski, M. Pérol	2020	8
16	Pulmonary function measurements in dolphins using capnography Veterinary Record ·C. E. van Elk, N. Epping, Steven Gans	2001	6
17	Postmastectomy Chest Wall Reirradiation With Proton Therapy for Breast Cancer International Journal of Radiation OncologyBiologyPhysics ·L.A. McGee, Z. Iftekaruddin, J. Chang, Vinai Gondi, S. Schmidt, D. Kaplan, Steven Gans, Mark Pankuch, William F. Hartsell	2017	5
18	Gemcitabine and Cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 Non-Small Cell Lung Cancer: A phase II study of the EORTC Lung Cancer Cooperative Group (EORTC 08955) Lung Cancer ·Nico van Zandwijk, E.F Smith, G. Kramer, Franz M.N.H. Schramel, Steven Gans, Jan Festen, A. Termeer, N.J.J. Schlösser, C. Debruyne, Desmond Curran, Giuseppe Giaccone	2000	4
19	6519 ORAL Favorable benefit to risk profile for pemetrexed plus cisplatin versus gemcitabine plus cisplatin in a large phase III study of first-line therapy in advanced non-small cell lung cancer European Journal of Cancer Supplements ·Giorgio V. Scagliotti, K. Park, Shekhar Patil, Janusz Rolski, T. Gorksel, Steven Gans, R Martins, Carla Visseren‐Grul, Patrick Peterson	2007	2
20	Denosumab versus zoledronic acid in patients with bone metastases from solid tumors other than breast and prostate cancers or multiple myeloma: A number needed to treat (NNT) analysis. Journal of Clinical Oncology ·Gary Richardson, Tudor–Eliade Ciuleanu, Luís Costa, Steven Gans, J. Á. Garcia Saenz, Vera Hirsh, Vânia Hungria, Maciej Krzakowski, C. Manegold, Hareth Nahi, Silvia Novello, Andreas Petzer, Michael Rader, Philippe Solal‐Céligny, Saroj Vadhan‐Raj, Johan Vansteenkiste, Penella J. Woll, Chunlei Ke, Ka‐Fai Chung, Hong‐Zen Yeh	2011	2

About Steven Gans

Steven Gans is a scholar working on Equine, Oncology, Pulmonary and Respiratory Medicine, Small Animals and Dermatology, having authored 20 papers that have together received 941 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers), Cancer therapeutics and mechanisms (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Asthma and respiratory diseases (2 papers) and Respiratory and Cough-Related Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (638 citations), Oncology (481 citations), Physiology (155 citations), Hepatology (45 citations) and Cancer Research (59 citations). Steven Gans has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Bonne Biesma, Péter Kardos, J. Thirlwell, Sergio Harari, Claus Vogelmeier, Stephan Stenglein, C. Debruyne, Giuseppe Giaccone, Catherine Legrand and Jan P. van Meerbeeck. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Respiratory Medicine, Lung Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact